Vaxart

Vaxart

Vaccine technology for the treatment of infectious diseases. Learn more

Launch date
Employees
Market cap
€186m
Enterprise valuation
€147m (Public information from Sep 2024)
San Francisco California (HQ)
Authorizing premium user...